SOX combined with intraperitoneal perfusion of docetaxel compared with DOS regimen in the first-line therapy for advanced gastric cancer with malignant ascites: a prospective observation

被引:0
|
作者
Yehong Bin
Dong Lan
Wenguang Bao
Haiyan Yang
Shengsheng Zhou
Fengxiang Huang
Man Wang
Zhigang Peng
机构
[1] the First Affiliated Hospital of Guangxi Medical University,Department of Oncology
来源
Trials | / 23卷
关键词
Advanced gastric cancer; Malignant ascites; Intraperitoneal infusion of chemotherapy; First-line chemotherapy; Docetaxel; S-1; Oxaliplatin;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [31] Combination therapy with docetaxel and S-1 as a first-line treatment in patients with advanced or recurrent gastric cancer: a retrospective analysis
    Tanabe, Kazuaki
    Suzuki, Takahisa
    Tokumoto, Noriaki
    Yamamoto, Hideki
    Yoshida, Kazuhiro
    Ohdan, Hideki
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2010, 8
  • [32] An exploratory clinical study of β-glucan combined with camrelizumab and SOX chemotherapy as first-line treatment for advanced gastric adenocarcinoma
    Chu, Yunqian
    He, Xuan
    Xue, Ya
    Jiang, Hua
    Zhu, Chan
    Qi, Chunjian
    Zhang, Xing
    Chen, Dongsheng
    Dai, Hanjue
    Xian, Qingying
    Zhu, Wenyu
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [33] Paclitaxel combined with oxaliplatin as first-line chemotherapy for locally advanced or metastatic gastric cancer
    Shi, Chunmei
    Chen, Qiang
    Shen, Songfei
    Wu, Riping
    Yang, Baoyu
    Liu, Qing
    Xu, Qian
    EXPERT REVIEW OF ANTICANCER THERAPY, 2015, 15 (05) : 595 - 601
  • [34] Impact of first-line treatment response on second-line therapy with nintedanib plus docetaxel in advanced lung adenocarcinoma after combined first-line immunochemotherapy
    Grohe, C.
    Wehler, T.
    Henschke, S.
    Dittrich, I
    Hammerschmidt, S.
    Aulmann, C.
    Dechow, T.
    Schiefer, C.
    von der Heyde, E.
    Schuette, W.
    Atz, J.
    Kaiser, R.
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 2) : 208 - 208
  • [35] Effect of autologous lymphocytes combined with chemotherapy as the first-line treatment of advanced gastric cancer
    Ma, Xiaoting
    Yang, Lin
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [36] Phase II study of biweekly docetaxel and cisplatin combination chemotherapy in first-line advanced gastric cancer
    Quintero, G., Sr.
    Jorge, M.
    Casal, J.
    Salgado, M.
    Candamio, S.
    Lopez, R.
    Mel, J. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [37] Phase II study of first-line biweekly docetaxel and cisplatin combination chemotherapy in advanced gastric cancer
    G. Quintero-Aldana
    M. Jorge
    C. Grande
    M. Salgado
    E. Gallardo
    S. Varela
    C. López
    M. J. Villanueva
    A. Fernández
    E. Alvarez
    P. González
    J. Castellanos
    J. Casal
    R. López
    B. Campos Balea
    Cancer Chemotherapy and Pharmacology, 2015, 76 : 731 - 737
  • [38] Phase II study of first-line biweekly docetaxel and cisplatin combination chemotherapy in advanced gastric cancer
    Quintero-Aldana, G.
    Jorge, M.
    Grande, C.
    Salgado, M.
    Gallardo, E.
    Varela, S.
    Lopez, C.
    Villanueva, M. J.
    Fernandez, A.
    Alvarez, E.
    Gonzalez, P.
    Castellanos, J.
    Casal, J.
    Lopez, R.
    Campos Balea, B.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 76 (04) : 731 - 737
  • [39] Efficacy and safety analysis of modified biweekly SOX regimen in the first-line treatment of advanced gastric adenocarcinoma or esophagogastric junction adenocarcinoma
    Zhang, S.
    Wang, H.
    Meng, Y.
    Nie, X.
    Huang, C.
    Gao, F.
    Sun, L.
    Liu, Z.
    ANNALS OF ONCOLOGY, 2020, 31 : S911 - S911
  • [40] Docetaxel and mitoxantrone, versus docetaxel mitoxantrone and letrozole as first-line therapy in advanced breast cancer: A randomized study.
    Gennatas, C
    Mouratidou, D
    Tsavaris, N
    Michalaki, V
    Psychogios, J
    Poulakaki, N
    Andreadis, C
    Diamantopoulos, N
    Gennatas, S
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 58S - 58S